FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will therefore address general information about [18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out, interpret, and document quantitative FDG PET/CT examinations, but will concentrate on the optimisation of diagnostic quality and quantitative information

Psychobiological characteristics of dissociative identity disorder:A symptom provocation study

Background: Dissociative identity disorder (DID) patients function as two or more identities or dissociative identity states (DIS), categorized as 'neutral identity states' (NIS) and 'traumatic identity states' (TIS). NIS inhibit access to traumatic memories thereby enabling daily life functioning. TIS have access and responses to these memories. Wee tested whether these DIS show different psychobiological reactions to trauma-related memory. Methods: A symptom provocation paradigm with 11 DID patients was used in a two-by-two factorial design setting. Both NIS and TIS were exposed to a neutral and a trauma-related memory script. Three psychobiological parameters were tested: subjective ratings (emotional and sensori-motor), cardiovascular responses (heart rate, blood pressure, heart rate variability) and regional cerebral blood flow as determined with (H2O)-O-15 positron emission tomography. Results: Psychobiological differences were found for the different DIS. Subjective and cardiovascular reactions revealed significant main and interactions effects. Regional cerebral blood flow data revealed different neural networks to be associated with different processing of the neutral and trauma-related memory script by NIS and TIS. Conclusions: Patients with DID encompass at least two different DIS. These identities involve different subjective reactions, cardiovascular responses and cerebral activation patterns to a trauma-related memory script

Left ventricular volume assessment by planar radionuclide ventriculography evaluated by MRI

Background Assessment of left ventricular (LV) ejection fraction (LVEF) and LV volume are essential for the evaluation of prognosis in cardiac disease. LVEF and LV volumes can be measured with several imaging modalities, such as magnetic resonance imaging (MRI) or computed tomography; however, these are relatively expensive and time consuming. In contrast, planar radionuclide ventriculography (PRV) for LVEF assessment is a cost-effective, fast, and reliable technique, but PRV for LV volumes calculation is less common. Aim Evaluation of a new hybrid geometrical count-based method (HGCBM) in comparison with two count-based methods (CBMs) and a geometrical method (GM) for the calculation of LV volumes with PRV using MRI as reference. Methods Thirty cardiac patients underwent routine PRV with a standard dose of 500 MBq of (99m)Tc-pertechnetate and additional cardiac MRI as reference method. LV volumes of PRV data were calculated by four different methods. The CBMs and GM are based on the assumption that the shape of the LV can be approximated by an ellipsoid or sphere, and the new HGCBM extracts the volume from the projected count rates themselves. Results All methods underestimated the LV volumes as compared with the MRI-measured volumes. The difference (mean +/- SD) of end-diastolic volume (EDV) between PRV and MRI was 33 +/- 23 ml for GM, 12 +/- 26 ml for HGCBM, 50 +/- 38 ml for CBM1, and 13 +/- 40 ml for CBM2. The correlation coefficients for EDV between PRV methods and MRI were r = 0.90 for GM and r = 0.85 for HGCBM. The CBMs showed poor correlation r = 0.64 with the MRI data and a high SD. The difference of end-systolic volume (ESV) between PRV and MRI was 23 +/- 19 ml for GM, 9 +/- 22 ml for HGCBM, 29 +/- 29 ml for CBM1, and 9 +/- 28 ml for CBM2. The correlation coefficients for ESV between PRV methods and MRI were r = 0.955 for GM and r = 0.914 for HGCBM, r = 0.85 for CBM1 and CBM2. Although GM showed a slightly higher correlation than HGCBM, the difference of EDV and ESV between PRV and MRI was much higher for GM in comparison with HGCBM. Both CBMs showed poor agreement with MRI data. Conclusion PRV using the new HGCMB method in comparison with other methods is an easy and accurate method to determine LV volumes. However, all methods underestimate ESV and EDV slightly as compared with MRI. Nucl Med Commun 30:727-735 (C) 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging—version 1.0. Eur J Nucl Med Mol Imaging

General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Contains fulltext : 70810.pdf (publisher's version ) (Closed access)INTRODUCTION: Several studies have shown the usefulness of positron emission tomography (PET) quantification using standardised uptake values (SUV) for diagnosis and staging, prognosis and response monitoring. Many factors affect SUV, such as patient preparation procedures, scan acquisition, image reconstruction and data analysis settings, and the variability in methodology across centres prohibits exchange of SUV data. Therefore, standardisation of 2-[(18)F] fluoro-2-deoxy-D-glucose (FDG) PET whole body procedures is required in multi-centre trials. METHODS: A protocol for standardisation of quantitative FDG whole body PET studies in the Netherlands (NL) was defined. This protocol is based on standardisation of: (1) patient preparation; (2) matching of scan statistics by prescribing dosage as function of patient weight, scan time per bed position, percentage of bed overlap and image acquisition mode (2D or 3D); (3) matching of image resolution by prescribing reconstruction settings for each type of scanner; (4) matching of data analysis procedure by defining volume of interest methods and SUV calculations and; (5) finally, a multi-centre QC procedure is defined using a 20-cm diameter phantom for verification of scanner calibration and the NEMA NU 2 2001 Image Quality phantom for verification of activity concentration recoveries (i.e., verification of image resolution and reconstruction convergence). DISCUSSION: This paper describes a protocol for standardization of quantitative FDG whole body multi-centre PET studies. CONCLUSION: The protocol was successfully implemented in the Netherlands and has been approved by the Netherlands Society of Nuclear Medicine